120 related articles for article (PubMed ID: 14949053)
1. Antimalarial activities of triazine metabolites of chlorguanide and dichlorguanide.
SCHMIDT LH; LOO TL; FRADKIN R; HUGHES HB
Proc Soc Exp Biol Med; 1952 Jun; 80(2):367-70. PubMed ID: 14949053
[No Abstract] [Full Text] [Related]
2. A statistical analysis of the antimalarial activity of proguanil and cycloguanil in human volunteers.
Yeo AE; Edstein MD; Shanks GD; Rieckmann KH
Ann Trop Med Parasitol; 1994 Dec; 88(6):587-94. PubMed ID: 7893172
[TBL] [Abstract][Full Text] [Related]
3. Superior antimalarial activity of proguanil to cycloguanil after in vitro bioconversion.
Ramanaiah TV; Gajanana A
Trans R Soc Trop Med Hyg; 1988; 82(3):358-9. PubMed ID: 3068842
[No Abstract] [Full Text] [Related]
4. Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates.
Edstein MD; Yeo AE; Shanks GD; Rieckmann KH
Acta Trop; 1997 Sep; 66(3):127-35. PubMed ID: 9210963
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the antimalarial activity of chlorguanide by pteroylglutamic acid.
GREENBERG J
Proc Soc Exp Biol Med; 1949 Jun; 71(2):306-8. PubMed ID: 18134046
[No Abstract] [Full Text] [Related]
6. THE EFFECT OF A REPOSITORY PREPARATION OF THE DIHYDROTRIAZINE METABOLITE OF CHLORGUANIDE, CI-501, AGAINST THE CHESSON STRAIN OF PLASMODIUM VIVAX IN MAN.
COATNEY GR; CONTACOS PG; LUNN JS; KILPATRICK JW; ELDER HA
Am J Trop Med Hyg; 1963 Jul; 12():504-8. PubMed ID: 14044760
[No Abstract] [Full Text] [Related]
7. [CROSSED RESISTANCE OF P. GALLINACEUM WITH RESPECT TO PROGUANIL AND ITS ACTIVE TRIAZINE METABOLITE].
BENAZET F
Bull Soc Pathol Exot Filiales; 1964; 57():371-5. PubMed ID: 14250509
[No Abstract] [Full Text] [Related]
8. Antifolate studies. Activities of 40 potential antimalarial compounds against sensitive and chlorguanide triazine resistant strains of folate-requiring bacteria and Escherichia coli.
Genther CS; Smith CS
J Med Chem; 1977 Feb; 20(2):237-43. PubMed ID: 137981
[TBL] [Abstract][Full Text] [Related]
9. PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists.
Canfield CJ; Milhous WK; Ager AL; Rossan RN; Sweeney TR; Lewis NJ; Jacobus DP
Am J Trop Med Hyg; 1993 Jul; 49(1):121-6. PubMed ID: 8352384
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of CI-564 against blood-induced chlorguanide-sensitive and chlorguanide-resistant strains of vivax malaria.
Chin W; Coatney GR; King HK
Am J Trop Med Hyg; 1967 Jan; 16(1):13-4. PubMed ID: 5336629
[No Abstract] [Full Text] [Related]
11. The inhibitory action of some antimalarial drugs and related compounds on the hexokinase of yeast and of Plasmodium berghei.
FRASER DM; KERMACK WO
Br J Pharmacol Chemother; 1957 Mar; 12(1):16-23. PubMed ID: 13413145
[TBL] [Abstract][Full Text] [Related]
12. The effect of cycloguanil pamoate (CI-501) against a chlorguanide-resistant Chesson strain of Plasmodium vivax.
Chin W; Lunn JS; Buxbaum J; Contacos PG
Am J Trop Med Hyg; 1965 Nov; 14(6):922-4. PubMed ID: 5320455
[No Abstract] [Full Text] [Related]
13. Analogues of N-benzyloxydihydrotriazines: in vitro antimalarial activity against Plasmodium falciparum.
Childs GE; Lambros C
Ann Trop Med Parasitol; 1986 Apr; 80(2):177-81. PubMed ID: 3530157
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand.
Edstein MD; Bahr S; Kotecka B; Shanks GD; Rieckmann KH
Antimicrob Agents Chemother; 1997 Oct; 41(10):2300-1. PubMed ID: 9333069
[TBL] [Abstract][Full Text] [Related]
15. Formation of the diuretic chlorazanil from the antimalarial drug proguanil--implications for sports drug testing.
Thevis M; Geyer H; Thomas A; Tretzel L; Bailloux I; Buisson C; Lasne F; Schaefer MS; Kienbaum P; Mueller-Stoever I; Schänzer W
J Pharm Biomed Anal; 2015 Nov; 115():208-13. PubMed ID: 26226108
[TBL] [Abstract][Full Text] [Related]
16. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro.
Watkins WM; Sixsmith DG; Chulay JD
Ann Trop Med Parasitol; 1984 Jun; 78(3):273-8. PubMed ID: 6385887
[TBL] [Abstract][Full Text] [Related]
17. The potentiation of the antimalarial activity of chloroguanide by p-aminobenzoic acid competitors.
GREENBERG J
J Pharmacol Exp Ther; 1949 Oct; 97(2):238-42. PubMed ID: 15391935
[No Abstract] [Full Text] [Related]
18. Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture.
Yeo AE; Seymour KK; Rieckmann KH; Christopherson RI
Ann Trop Med Parasitol; 1997 Jan; 91(1):17-23. PubMed ID: 9093425
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
[TBL] [Abstract][Full Text] [Related]
20. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase.
Fidock DA; Nomura T; Wellems TE
Mol Pharmacol; 1998 Dec; 54(6):1140-7. PubMed ID: 9855645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
